Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India flag India · Delayed Price · Currency is INR
4,297.90
-71.30 (-1.63%)
Mar 4, 2026, 11:00 AM IST

Torrent Pharmaceuticals Statistics

Total Valuation

NSE:TORNTPHARM has a market cap or net worth of INR 1.48 trillion. The enterprise value is 1.50 trillion.

Market Cap 1.48T
Enterprise Value 1.50T

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date May 22, 2026
Ex-Dividend Date Feb 18, 2026

Share Statistics

Current Share Class 338.45M
Shares Outstanding n/a
Shares Change (YoY) +0.03%
Shares Change (QoQ) -0.11%
Owned by Insiders (%) 0.28%
Owned by Institutions (%) 17.34%
Float 103.98M

Valuation Ratios

The trailing PE ratio is 65.11 and the forward PE ratio is 60.64.

PE Ratio 65.11
Forward PE 60.64
PS Ratio 11.61
PB Ratio 17.51
P/TBV Ratio 36.38
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 66.00
EV / Sales 11.77
EV / EBITDA 36.34
EV / EBIT 44.70
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.33
Debt / EBITDA 0.68
Debt / FCF n/a
Interest Coverage 16.42

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 24.19%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 4.98%
Revenue Per Employee 7.47M
Profits Per Employee 1.33M
Employee Count 17,059
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NSE:TORNTPHARM has paid 7.36 billion in taxes.

Income Tax 7.36B
Effective Tax Rate 24.46%

Stock Price Statistics

The stock price has increased by +48.20% in the last 52 weeks. The beta is 0.13, so NSE:TORNTPHARM's price volatility has been lower than the market average.

Beta (5Y) 0.13
52-Week Price Change +48.20%
50-Day Moving Average 4,032.31
200-Day Moving Average 3,653.10
Relative Strength Index (RSI) 67.10
Average Volume (20 Days) 415,599

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:TORNTPHARM had revenue of INR 127.42 billion and earned 22.72 billion in profits. Earnings per share was 67.12.

Revenue 127.42B
Gross Profit 96.38B
Operating Income 33.55B
Pretax Income 30.08B
Net Income 22.72B
EBITDA 41.03B
EBIT 33.55B
Earnings Per Share (EPS) 67.12
Full Income Statement

Balance Sheet

The company has 7.94 billion in cash and 28.22 billion in debt, with a net cash position of -20.28 billion.

Cash & Cash Equivalents 7.94B
Total Debt 28.22B
Net Cash -20.28B
Net Cash Per Share n/a
Equity (Book Value) 84.49B
Book Value Per Share 249.47
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 75.64%, with operating and profit margins of 26.33% and 17.83%.

Gross Margin 75.64%
Operating Margin 26.33%
Pretax Margin 23.61%
Profit Margin 17.83%
EBITDA Margin 32.20%
EBIT Margin 26.33%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.81%.

Dividend Per Share 35.00
Dividend Yield 0.81%
Dividend Growth (YoY) 9.38%
Years of Dividend Growth 2
Payout Ratio n/a
Buyback Yield -0.03%
Shareholder Yield 0.78%
Earnings Yield 1.54%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.

Last Split Date Jul 8, 2022
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score 1